In this podcast, Charles Flexner, MD, speaks about the current state of long-acting agents for the management of patients with HIV, HIV prevention and vaccines, and HIV pathogenesis and cure. Dr...
In this podcast, Samantha Hill, MD, MPH, FAAP, discusses considerations and challenges for health care practitioners in the prevention and management for HIV in adolescent patient populations, including...
In this video, Melissa E. Badowski, PharmD, MPH, discusses guidelines for hepatitis B virus (HBV) screening and vaccination in patients prescribed human immunodeficiency virus (HIV) pre-exposure prophylaxis...
In this podcast, Jeffrey Kwong, DNP, MPH, ANP-BC, discusses the use of HIV pre-exposure prophylaxis (PrEP) in older adults, its safety and efficacy in this patient population, and what barriers exist for...
In this interview, Jessica Rodrigues, MS, answers questions about barriers to the access of pre-exposure prophylaxis (PrEP), funding, stigma, and choices of PrEP. She also spoke about these topics during...
In this podcast, Jessica Rodrigues, with AVAC: Global Advocacy for HIV Prevention, speaks about ways communities can overcome barriers to the access of pre-exposure prophylaxis (PrEP), including ambitious...
In this podcast, Jessica Rodrigues, with AVAC: Global Advocacy for HIV Prevention, provides a description of a Dual Prevention Pill and why it can be used as a case study for future multipurpose...
PrEP has become more mainstream in the media, and the USPSTF recently recommended PrEP for all at-risk populations. Richard Chaisson, MD, shines light on these at-risk populations.
In this short video, Jordan Feld, MD, MPH, talks about his team's latest research on hepatitis C virus infections among patients taking pre-exposure prophylaxis for HIV infection.
In this Q&A, Monica Gandhi, MD, MPH, discusses interventions to address the health care disparities that exist along the care continuum for certain patient populations who are at-risk for HIV...
